AstraZeneca COVID shot less effective on South Africa variant

72
Published on February 7, 2021 by

AstraZeneca said that its vaccine developed with the University of Oxford appeared to offer limited protection against mild disease caused by the South African variant of COVID-19

Category Tag
0 0 votes
Article Rating
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments